Appointment of Joint Broker

By

Regulatory News | 08 Aug, 2019

Updated : 07:07

RNS Number : 3251I
Emmerson PLC
08 August 2019
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

8 August 2019

Appointment of Joint Broker

 

Emmerson Plc, the Moroccan focused potash development company, is pleased to advise that it has appointed Shard Capital Partners LLP to act as joint broker to the Company with immediate effect.

 

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

 

Hayden Locke

Emmerson Plc

Tel: +44 (0) 207 236 1177

Edward McDermott

 



Jeremy King

 

Optiva Securities Limited

Joint Broker

Tel: +44 (0) 3137 1904

 

Damon Heath

Isabella Pierre

 

Shard Capital Partners

 

Tel:  020 7186 9950




Gaby Jenner

Melissa Hancock

St Brides Partners Ltd

Financial PR/IR

Tel: +44 (0) 20 7236 1177


 

 

**ENDS**


 

 

Notes to Editors

Emmerson's primary focus is on developing the Khemisset Potash Project located in Northern Morocco.  The project has a large JORC Resource Estimate (2012) of 311.4Mt @ 10.2% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine.  Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPEAFPXELPNEAF

Last news